Position in CDNA
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$654,274
New position
Shares Held
22,957
first reported quarter
Ownership
0.044%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#114
of 225 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 3%
Shared 0%
None 97%
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Corient Private Wealth LLC holds $750,824,495 across 25 Diagnostics & Research names. CDNA ranks #21 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
16,187,054 | $382,526,542 | |
| 2 | DHR |
Danaher Corp /De/
|
705,975 | $134,474,118 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
115,405 | $60,753,808 | |
| 4 | MTD |
Mettler Toledo International Inc/
|
26,295 | $33,592,125 | |
| 5 | A |
Agilent Technologies, Inc.
|
243,555 | $32,351,410 | |
| 6 | ICLR |
Icon PLC
|
114,844 | $19,949,551 | |
| 7 | RVTY |
Revvity, Inc.
|
162,985 | $18,133,711 | |
| 8 | ILMN |
Illumina, Inc.
|
91,197 | $16,035,168 |
All Filings in CDNA
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $654,274 | 22,957 | Shares | Sole | 2026-08-17 | |
| No filing history on record for this holder in this stock. | ||||||